Sionna Therapeutics (SION) Invested Capital (2024 - 2026)

Sionna Therapeutics has disclosed Invested Capital across 3 years of filings, most recently posting $288.2 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $288.2 million, down 18.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $288.2 million (down 18.07% YoY), and the FY2025 annual result was $306.8 million, up 287.42% from the prior year.
• Invested Capital came in at $288.2 million for Q1 2026 at Sionna Therapeutics, down from $306.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $351.8 million in Q1 2025 to a low of -$163.7 million in Q4 2024.
• The 3-year median for Invested Capital is $288.2 million (2026), against an average of $114.8 million.
• Across the five-year window, Invested Capital surged 379.0% in 2025 and declined 18.07% in 2026, its largest moves.
• Sionna Therapeutics' Invested Capital stood at -$163.7 million in 2024, then soared by 287.42% to $306.8 million in 2025, then retreated by 6.07% to $288.2 million in 2026.
• The last three Invested Capital figures came in at $288.2 million (Q1 2026), $306.8 million (Q4 2025), and $321.7 million (Q3 2025), per Business Quant data.